Upgrade to SI Premium - Free Trial

Barclays Reiterates Overweight Rating on Strategy (MSTR)

February 6, 2025 6:49 AM
Barclays analyst Ramsey El-Assal reiterated an Overweight rating and $515.00 price target on Strategy (NASDAQ: MSTR)The analyst comments "Key Takeaways ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles